Regulatory News
Tuesday, November 22, 2016
BRIEF-Alfataliglicerase approved for pediatric indications in Brazil for the treatment of gaucher disease in children four years and older
* Alfataliglicerase approved for pediatric indications in
brazil for the treatment of gaucher disease in children four
years and older
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment